Interleukin-1 Receptor Signaling and Attenuated Hepatic Cytochrome P450 2C Expression: Explanation for Higher Rate of Clopidogrel Resistance in Patients with Diabetes Mellitus?
| dc.contributor.author | Kreutz, Rolf P. | |
| dc.contributor.department | Medicine, School of Medicine | en_US |
| dc.date.accessioned | 2022-12-08T18:42:43Z | |
| dc.date.available | 2022-12-08T18:42:43Z | |
| dc.date.issued | 2020-06 | |
| dc.eprint.version | Author's manuscript | en_US |
| dc.identifier.citation | Kreutz RP. IL-1R (Interleukin-1 Receptor) Signaling and Attenuated Hepatic CYP (Cytochrome P450) 2C Expression: Explanation for Higher Rate of Clopidogrel Resistance in Patients With Diabetes Mellitus?. Arterioscler Thromb Vasc Biol. 2020;40(6):1429-1431. doi:10.1161/ATVBAHA.120.314446 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/30678 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | American Heart Association | en_US |
| dc.relation.isversionof | 10.1161/ATVBAHA.120.314446 | en_US |
| dc.relation.journal | Arteriosclerosis, Thrombosis, and Vascular Biology | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Editorials clopidogrel | en_US |
| dc.subject | Interleukin | en_US |
| dc.subject | Isoenzymes | en_US |
| dc.subject | Metabolic syndrome | en_US |
| dc.title | Interleukin-1 Receptor Signaling and Attenuated Hepatic Cytochrome P450 2C Expression: Explanation for Higher Rate of Clopidogrel Resistance in Patients with Diabetes Mellitus? | en_US |
| dc.type | Article | en_US |